Qianzhou Lv
机构：Zhongshan Hospital · ORCID：0000-0002-6353-7767
发表论文 50 篇 · 总被引 402 次 · h-index 12
代表论文
- Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation (2023 · Cardiovascular Drugs and Therapy · 被引 15)
- Vancomycin combined with piperacillin/tazobactam increases the risk of acute kidney injury compared with vancomycin plus other anti-pseudomonal beta-lactams: a systematic review and network meta-analysis (2024 · Journal of Antimicrobial Chemotherapy · 被引 13)
- A Novel Biomarker Scoring System Alone or in Combination with the GRACE Score for the Prognostic Assessment in Non-ST-Elevation Myocardial Infarction (2022 · Clinical Epidemiology · 被引 9)
- Effectiveness and safety evaluation of sacubitril/valsartan in blood pressure control and clinical outcomes for elderly patients with heart failure and hypertension: A prospective cohort study (2022 · International Journal of Cardiology · 被引 8)
- Clinical Effectiveness and Safety Comparison between Reduced Rivaroxaban Dose and Dual Antiplatelet Therapy for Nonvalvular Atrial Fibrillation Patients Following Percutaneous Left Atrial Appendage Closure: A Prospective Observational Study (2023 · Reviews in Cardiovascular Medicine · 被引 7)
- Effectiveness and safety of sacubitril/valsartan for patients with hypertension and heart failure in the real‐world setting: A retrospective study in China (2022 · Journal of Clinical Pharmacy and Therapeutics · 被引 7)